nitisinone has been researched along with Cognitive Decline in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aldámiz-Echevarría, L; Bueno, M; Couce, ML; Díaz-Fernández, C; García-Volpe, C; Gil, D; Hernández, T; López-Ruzafa, E; Martín-Hernández, E; Navas, V; Peña-Quintana, L; Pintos, G; Roca, I; Sánchez-Pintos, P; Sánchez-Valverde, F; Vitoria, I | 1 |
| Bendadi, F; de Koning, TJ; de Sain, MG; Prinsen, HC; Sinnema, G; van Hasselt, PM; van Spronsen, FJ; Verhoeven-Duif, N; Visser, G | 1 |
2 other study(ies) available for nitisinone and Cognitive Decline
| Article | Year |
|---|---|
Evolution of tyrosinemia type 1 disease in patients treated with nitisinone in Spain.
Topics: Adult; Child; Cognitive Dysfunction; Cyclohexanones; Delayed Diagnosis; Enzyme Inhibitors; Female; Follow-Up Studies; Humans; Infant, Newborn; Kidney Diseases; Male; Needs Assessment; Neonatal Screening; Nitrobenzoates; Obesity; Prognosis; Quality of Life; Retrospective Studies; Spain; Time-to-Treatment; Tyrosinemias | 2019 |
Impaired cognitive functioning in patients with tyrosinemia type I receiving nitisinone.
Topics: 4-Hydroxyphenylpyruvate Dioxygenase; Adolescent; Child; Child Development; Child, Preschool; Cognition; Cognitive Dysfunction; Cross-Sectional Studies; Cyclohexanones; Disease Progression; Enzyme Inhibitors; Female; Humans; Incidence; Male; Netherlands; Nitrobenzoates; Prognosis; Risk Factors; Tyrosinemias; Young Adult | 2014 |